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Abstract
Background: Detailed structural knowledge of enzyme-inhibitor complexes trapped in intermediate state is the key
for a fundamental understanding of reaction mechanisms taking place in enzymes and is indispensable as a
structure-guided drug design tool. Solution state NMR uniquely allows the study of active sites of enzymes in
equilibrium between different tautomeric forms. In this study 1H, 19F and 15 N NMR spectroscopy has been used
to probe the interaction contacts of inhibitors locked in transition states of the catalytic triad of a serine protease. It
was demonstrated on the serotype II Dengue virus NS2B:NS3pro serine protease and its mutants, H51N and S135A,
in complex with high-affinity ligands containing trifluoromethyl ketone (tfk) and boronic groups in the C-terminal of
tetra-peptides.
Results: Monitoring 19F resonances, shows that only one of the two isomers of the tfk tetra-peptide binds with
NS2B:NS3pro and that access to the bulk of the active site is limited. Moreover, there were no bound water found
in proximity of the active site for any of the ligands manifesting in a favorable condition for formation of low
barrier hydrogen bonds (LBHB) in the catalytic triad. Based on this data we were able to identify a locked
conformation of the protein active site. The data also indicates that the different parts of the binding site most
likely act independently of each other.
Conclusions: Our reported findings increases the knowledge of the detailed function of the catalytic triad in serine
proteases and could facilitate the development of rational structure based inhibitors that can selectively target the
NS3 protease of Dengue type II (DENV2) virus. In addition the results shows the usefulness of probing active sites
using 19F NMR spectroscopy.
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Background
Dengue virus (DENV), with its four common serotypes
(DENV 1–4), transmitted predominantly in tropical and
subtropical regions by the mosquito Aedes aegypti, is
currently increasing worldwide, infecting millions of
people and causing dengue fever, dengue hemorrhagic
fever, and dengue shock syndrome [1]. It belongs to the
flavivirus genus, which also includes Zika virus [2, 3],
West Nile virus (WNV) [4], and Yellow Fever virus
(YFV) [5]. The flaviviral RNA genome consists of one
open chain, encoding a single polyprotein including three
structural proteins (C, prM, and E) and seven nonstruc-
tural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and
NS5) [6]. It was originally believed that the NS3 domain
encoded the functional protease. However later studies
showed that the protease is a two component system [7].
In this dimeric protease the virally encoded serine prote-
ase lies in the N-terminal protease domain of NS3
(NS3pro), with NS2B serving as a cofactor. A segment of
minimally 40 residues (amino acids 1394–1440 of the
polyprotein) suffices for full proteolytic activity of NS3pro
[8]. The NS2B:NS3pro serine proteases have been studied
intensively due to their critical role in polyprotein matur-
ation and viral infectivity [9].
The complexity of the ‘open’ and ‘closed’ conforma-
tions of DENV protease and the significance of a cova-
lent linker between NS2B and NS3 for enzyme activity
and structure has been a topic of much discussion in re-
cent years, and was recently summarized by Hill et al.
[9]. Their findings suggest that unlinked constructs are
better suited for future drug development efforts. We re-
cently assigned unlinked DENV2 NS2B:NS3pro in com-
plex with boronic acid inhibitor (I) where all key amino
acids in the catalytic triad and oxyanion hole were suc-
cessfully identified (BMRB 26996), [10]. This was lacking
in the earlier reported NMR assignments performed on
the linked construct.
A common feature of serine proteases is the His-Asp-
Ser catalytic triad; for DENV NS3pro the catalytic resi-
dues are H51, D75 and S135. The exact nature of the
hydrogen bonds in the catalytic triad is of importance in
order to understand the mechanism. It has been sug-
gested that the aspartate hydrogen bond to the histidine
is a delocalized low barrier hydrogen bond (LBHB) [11,
12]. LBHB is thus important to the understanding of the
structure of the tetrahedral transition state for the func-
tioning enzyme. Other parts involved in the protease
function are: the peptide binding site and the oxyanion
hole which stabilizes the negative charge on a deproto-
nated oxygen [13]. There are several reports on serine
proteases where the interaction between the catalytic
triad and boronic or aldehyde substrate analogue inhibi-
tors have been studied and there is an understanding
that in different type of serine proteases different
mechanisms could prevail involving different modes of
inhibitor binding [12–18]. Remarkably, in the x-ray
structure of West Nile virus (WNV) NS2B:NS3pro with
a short peptide boronic acid type of inhibitor recently
obtained the inhibitor orientation in the active site is
complemented by interaction with an additional
molecule, glycerol, present in the enzyme [19]. This indi-
cates that catalytic active site in serine proteases could
exhibit high plasticity in an apparent mobile
environment.
In our earlier NMR studies we demonstrated the exist-
ence of the above mentioned LBHB between H51 and
D75 of the catalytic triad in the transition state of
DENV2 NS2B:NS3pro with substrate-analogue boronic
acid inhibitor Bz-Nle-Lys-Arg-Arg-B(OH)2, (compound
I, Table 1) [20]. To our knowledge, this is the first time
the existence of a LBHB type complex in serine prote-
ases, as has been predicted [12], could be demonstrated
by NMR spectroscopy in a biological system. The un-
usual large low-filed shift of Nδ1H (19.93 ppm) of H51
combined with a N-H splitting of only 52 Hz clearly in-
dicated the presence of LBHB [20].
There are several recent papers where the conform-
ation of inhibited dengue protease is studied by NMR
spectroscopy [21–24]. Despite this recent progress there
are unanswered questions related to the conformation of
the inhibitor-trapped catalytic triad and the role of
NS2B in catalysis. In this study we focused primary on
the first of these questions. We used 1H, 19F and 15N
NMR spectroscopy to study an unlinked construct of
DENV2 NS2B:NS3pro in complex with two different in-
hibitor types presumably mimicking the intermediate
stage of substrate binding: a boronic acid (I) and a set of
trifluoromethyl keton (tfk) inhibitors (II)-(V) (Table 1).
The analysis of the chemical shift perturbations (CSP)
differences of the backbone of the parent NS2B:NS3pro
protein and its catalytic mutants, S135A and H51N, in-
duced by boronic (I) and tfk (II)-(V) inhibitors, allow us
to study conformational changes in the active site. We
believe that a better understanding of the atomic inter-
actions in the active site will ultimately lead to improved
NS3 protease-targeting drugs.
Results
Complexes of the dengue II NS2B:NS3pro protein with
peptide type -CF3-ketone inhibitors
Monitoring of the binding ability of the peptide type -CF3-
ketone isomers to the NS2B:NS3pro by 19F NMR
The subside part of peptide types of inhibitors either im-
proves or prevents correct binding with the enzyme in
the most favourable way [16]. One way to probe stereo-
selectivity in enzymes is to study an inhibitor with the
wrong stereochemistry around the carbon, Cα, of the P1
(Arg) (for abbreviation see Table 1). The key question is:
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Table 1 Structures and abbreviations of the compounds used in this study
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could both isomers bind to NS2B:NS3pro complex? If
yes, is there any difference in affinity between them. To
challenge these questions two separated diastereomers
of Ph-Bz-Lys-Lys-Arg-CF3-ketone (III) (Table 1) with
low affinity were used to observe the binding. The iso-
lated diastereomers were kept in solution with and with-
out the NS2B/NS3 complex for two months with
measuring at several points. For the first separated iso-
mer (IIIa), only one 19F resonance is observed at − 82.83
ppm in the unbound state (Fig. 1a). After two months
some small amount of isomer (IIIb) can be seen to ap-
pear. With the addition of protein there are two signals
(Fig. 1b): the downfield broad signal at − 80.84 ppm belong-
ing to the ligand in the bound state and the more upfield
signal at − 82.83 ppm belonging to the unbound inhibitor.
For the second isomer (IIIb) the unbound signal is located
at − 82.78 ppm (Fig. 1c), note that it is not 100% pure some
amount of isomer (IIIa) can be seen. With protein addition,
the signal of the bound complex at − 80.85 ppm is observed
only at the noise level (Fig. 1d), which indicates that affinity
Fig. 1 19F spectra for CF3 ketones (IIIa and IIIb) with NS2B:NS3pro. Superposition of
19F spectra between − 80.5 to − 81.5 (intensities scaled
up 16 times) and − 82.3 to − 83.3 ppm obtained at 25 °C. Spectra were collected: shortly after sample preparation (black), following incubation at
25 °C for 12 days (red) and for two months (blue). The signals of the free isomers of the inhibitors at − 82.83 ppm and – 82.78 ppm are assigned
to (IIIa) and (IIIb), correspondingly. Impurity signals are marked with *
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is very low. After 2months incubation of the samples at
25 °C (blue line Fig. 1b, d) the fraction in bound state of the
complex is not observed, instead two signals of unbound lig-
and at − 82.78 and – 82.83 ppm belonging to the isomers
(IIIb) and (IIIa) respectively. The epimerisation is fully
complete for isomer (IIIb) compared to isomer (IIIa) (Fig.
1d). In the spectra without protein the signals showed only a
minor change in intensity due to epimerization (Fig. 1a, c).
NS2B:NS3pro binds to one isomer of the racemic mixture of
Bz-Nle-Lys-Arg-Arg-CF3-ketone (II)
A racemic mixture of Cα of the P1 (Arg) in the free state
of (IV) was manifested by the presence of two sets of
signals in the 19F spectrum: at − 82.75 ppm (isomer IVb)
and − 82.82 ppm (isomer IVa). In accordance with the
data presented above for tfk III, for tfk type IV isomer
IVb was expected to have lower affinity than IVa. In-
deed, by replacing tfk (IV) in complex with NS2B:
NS3pro with the more potent boronic (I) inhibitor, the
signal of only one isomer (IVa) re-appeared (Fig. S1). It
was concluded, firstly, that for all tfk type inhibitor (II),
(IV) and (V) the high affinity isomer has more upfield
19F signals. Secondly, that NS2B:NS3pro binds only one
of the tfk isomers.
Limited access of bulk and bound water to the active site
of the complex of NS2B:NS3pro with boronic (I) and tfk
(II) inhibitors
Probing water accessibility of the NS2B:NS3pro complex
with tfk inhibitor by 19F NMR
The accessibility of water in the binding site of the com-
plex with bound inhibitor was tested by studying the 19F
spectra of the complexes NS2B:NS3pro (II) in two differ-
ent solvents: H2O and D2O (Fig. S2). No shift of the
19F
resonance at − 81.36 ppm belonging to the –CF3 group
of the bound inhibitor (II) was observed in contrast to
the signal in form the free inhibitor which moved up
field by ca 33 Hz (Fig. S2b). This data indicates that the
warhead of the ligand is deeply buried in the body of the
protein complex and that there is limited access of bulk
water in the active site. Noteworthy, that for 19F of the
benzene ring signals of the bound complex located at −
114.57 ppm an upfield shift of ca 38 Hz was observed.
This CSP was scaled versus the signals of the same
group of the unbound ligand, ca 48 Hz (Fig. S2c). The
conclusion is that 19F nuclei of the benzene ring of the
bound inhibitor are partly exposed to the solvent even in
the bound state.
Bound water in the complex of NS2B:NS3pro with inhibitors
(I) and (II)
To identify the presence of bound water in the NS2B:
NS3pro ligand complexes we used an approach devel-
oped by us earlier in which one can differentiate
between bulk water and more tightly bound water using
[25]. In the current study the advantages of the unlinked
NS2B:NS3pro construct was exploited, allowing separate
detection of NH contacts with closely located bound
water either for NS2B or NS3pro.
The superposition of the 2D plane 1H-15N of the 3D ex-
periment for water detection of NS2B:NS3pro complexed
with (I) and (II) are presented in Fig. S3. For both inhibi-
tors (I) and (II) very similar water interaction patterns can
be observed (Fig. S3). Indeed, the cross peaks for amide
protons of NS3pro with largest intensity attributed to the
contacts with bound water were observed in both inhibi-
tor complexes: K15, W89; R107, G121, S127, S131, N152,
G153, A166, G159, V169, (Fig. S3a and b). Many cross
peaks showing amide protons involved in exchange with
bulk water are in the crowded center of the spectrum but
some are clearly observed outside this area: Y33, I36, G32,
S68, G103, N105, T122, D129 and I182. A few bound
water contacts with amide protons in the complex NS2B:
NS3pro with (I) were registered for NS2B: S70, I73, D81
and M84 (Fig. S3a). The corresponding cross peaks of
amide protons involved in exchange with bulk water are:
R55, A65, G69, S71 and E80.
Significantly all amide protons involved in detected
contacts either with bound or bulk waters are away from
the catalytic triad. These data lead us to two conclusions.
Firstly, despite the difference in the warheads which thus
have different type of interactions of inhibitors (I) and
(II) in the catalytic triad, the similarity in bound waters
suggests only minor implications on the overall architec-
ture of the water pattern. Secondly, not observing either
bound or bulk water in proximity to the active site of
NS2B:NS3pro indicates that the conditions in the tetra-
hedral intermediates are hydrophobic and are optimal
for creation of LBHB bonds in the catalytic triad [11].
Interaction in the oxyanion hole of NS2B:NS3pro bound
to boronic (I) and tfk (II) inhibitors
The active site of serine proteases consists of a catalytic
triad (S135-H51-D75 for DENV2 NS3), but also an oxy-
anion hole. It has been discussed that the oxyanion hole
plays an important role in stabilizing the tetrahedral
intermediate during the attack by a substrate in the ac-
tive site of the enzyme forming a Michaelis complex
[13]. The effective interaction of the substrate-based
tetra-peptide inhibitors with oxyanion hole varies de-
pending on the type of warhead [12, 16].
To identify the interactions of inhibitors (I) and (II) in
the oxyanion hole, a reliable assignment of the amide
group resonances belonging to the active site of the
NS3pro should be achieved. We had observed that the
apo protein was prone to degradation, which made as-
signment challenging. Instead, we compared data sets
available in the public domain with assignment of the
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DENV2 NS2B:NS3pro apo form [26], complexes with
small molecules [27], tfk type of inhibitor (deposited to
BMRB id 19,305) [21], complex with aprotinin (deposited
to BMRB id 18,266) [28], and with boronic type of inhibi-
tors [29], and by us (deposited to BMRB id 26,996), [10].
For the catalytic triad, the assignments of H51 and D75
are corroborated for all data sets. The differences between
the data sets are mainly related to the fragment of NS3pro
sequence between two prolines P132-G133-T134-S135-
G136-S137-P138 forming the oxyanion hole. These ob-
served discrepancies are possibly due to differences in
interaction between different type of ligands and active
sites. In some cases the resonances were not assigned.
In our earlier study we have unambiguously assigned
the resonances of amide groups belonging to the S137,
G136, S135, T134 and G133 residues of the NS3pro in
complex with tetra peptide boronic acid inhibitor (I)
[10]. Unfortunately it was not possible to compare our
assignment with the closest analogue, the dipeptide bo-
ronic acid inhibitor, due to the incomplete assignment
[29]. Comparison of the amide chemical shift of the oxy-
anion hole between complex and apo form shows that
CSP induced by the boronic acid is not large (ca 0.3
ppm). This is much less than expected if an OH group/
or groups of the boronic tetrahedral intermediate is in-
volved in hydrogen bonding with NH of the oxyanion
hole or other direct contacts.
In contrast, in the complex formed with tfk type in-
hibitor (II), a strong down field shift of amide reso-
nances S135 and G133 are detected (for 1H ca 3 and 4
ppm respectively; Fig. 2 and Fig. S4). This is in good
agreement with HCV NS4A:NS3 complexes earlier re-
ported where the hemi-ketal oxygen of the tetrahedral
intermediate is involved in a hydrogen bond with the
NH of oxyanion hole amides [30].
It is expected that the D75 side chain can form hydro-
gen bonds not only with the Hδ1 side chain hydrogen of
H51 but also with its backbone hydrogen. Indeed it was
shown for HCV NS4A:NS3 [31] that a H51-HN
chemical-shift of ca 10.6 ppm was observed which is
consistent with the formation of a H51-HN….D81-Oδ
hydrogen bond seen in crystal structures (numbering
given in [31]). In the apo DENV2 NS2B:NS3pro the
H51-HN is observed as a double peak (ca 10.56/114.44
and 10.18/114.37 ppm). In the tfk (II) complex the
1H/15N of H51-HN moves up-field (9.17/112.28 ppm),
while in the boronic acid (I) complex it moves up-field
but to a lesser degree (10.03/113.50 ppm; Fig. S5) indi-
cating that hydrogen bonding between H51-HN and
D75-Oδ is weakened in both cases but to different ex-
tent. In an X-ray structure obtained for WNV NS2B-
NS3pro with a boronic dipeptidic inhibitor the distance
between the corresponding positions is 2.67 Å, indicating
the possibility to form a hydrogen bond [19].
Fig. 2 1H-15N TROSY spectra of 15N labeled NS3pro, unlabeled NS2B with inhibitors (I, II). Superposition of the 1H-15N TROSY spectra of 15N
labeled NS3pro, unlabeled NS2B with boronic acid (I) and tfk (II) inhibitors are shown in blue and red, respectively. The cross peaks of amino
acids with the largest CSP are connected by arrows and marked according to the residue number in sequence
Agback et al. BMC Molecular and Cell Biology           (2020) 21:38 Page 6 of 15
Low field 1H of NS2B:NS3pro complexed with boronic
acid (I) and tfk (II) inhibitors
Adding (I) and (II) inhibitor to NS2B:NS3pro leads to a
significant change in the 1H low field part of the
spectrum between 20 and 13 ppm compared to the apo
form where no resonances were observed in this region.
The presence in extreme low field of a singlet signal at
19.11 ppm of 15N13C-labeled NS2B:NS3pro with (II)
(Fig. 3a and b) is well in agreement with other NMR
studies of proteases in complex with a similar type of tfk
inhibitor [11, 32–35]. Its line width is ca 55 Hz which is
broader than the line widths for another imide protons
(ca 35 Hz) and it does not change when unlabeled
NS3pro is used (Fig. 3b). Noteworthy, we also fail to ob-
serve one bond splitting with 15N nuclei and any correl-
ation in 1H-15N TROSY spectrum even at lower temp
(5οC) (data not shown). The chemical shift of this reson-
ance is pH independent in the range between 5.5 and
8.5 which corroborates earlier reports for chymotrypsin
protease [32]. Indeed, for a non-hydrogen bonded histi-
dine, when participating in complex formation it would
be expected to show chemical shift dependence on pH
whereas histidine bound in a complex would not [36–
38]. But there is a difference. Indeed the intensity of the
signal for the N-AcF-CH3 complex reported by Cassidy
et al. persists at pH as high as 10 and then falls off
sharply [32]. But for NS2B:NS3pro bound to (II) the in-
tensity depends on pH with the largest peak observed at
pH 6.0 (Fig. S6).
Low field 1H NMR spectra of 15N13C-labeled NS2B:
NS3pro with inhibitor (I) (Fig. 3c-e) are different com-
pared to the spectrum of the complex inhibitor II (Fig.
3a, b). As has been reported earlier by us there are four
signals observed between 20.1–19.6 ppm and two signals
around 15.59 ppm (Fig. 3c) of NS2B:NS3pro with I at
pH = 6.0 and one singlet for complex with II [20]. When
NS3pro is unlabeled (Fig. 3e) or when decoupling of the
15N nuclei is applied (data not shown) the resonances
are reduced to two signals at 19.93 ppm and 19.77 ppm,
and one signal at 15.57 ppm. The JNH couplings are 52
Hz, 52 Hz and 90 Hz correspondingly (Fig. 3 c, d). None
of the signals in this region shift between pH 5.5 and 8.5
on their chemical shift, so H51 remains fully protonated
and H-bonded over the investigated pH range. The most
intense signal at 19.77 (Fig. 3d) is the most persistent in
all spectra at different buffers and pH (Fig. 3 c, d, e).
The other two signals at 19.93 and 15.57 are not always
observed and depend on sample conditions (e.g.
Figure 3d,e Tris buffer pH 8.5). The signals at 19.93 and
19.77 ppm were attributed to (N)Hδ1 of His 51 [20]. The
proposed assignment corroborates observations in X-ray
structures of Dengue type proteases showing a possible
hydrogen bonding between Nδ1 of a histidine and aspar-
tic acid. Further proof that those signals belong to the
H51 in the catalytic triad is that in the spectra of the
H51N mutant in complex with (II) inhibitors there were
no low field signals similar to 19.93, 19.77 and 15.57 ppm.
Characterization of S135A and H51N mutants
Peptide boronic acid (I) and tfk (II) inhibitors do not interact
with the S135A mutant
To understand the role of the catalytic S135 in the inter-
action with the boronic and tfk inhibitors, 15N13C-la-
beled NS2B:NS3pro (S135A) mutant was produced. The
1H-15N TROSY spectrum of the apo form of the S135A
mutant is very similar to the corresponding spectrum of
the wild-type NS2B:NS3pro (Fig. S7). Almost all CSPs
detected were below 0.1 ppm. The largest CSPs were ob-
served for H51 and G136 (Fig. S7a). For some cross
peaks that are clearly detected as single in the spectrum
of the S135A, in the wild-type protein a second cross
peak with weaker intensity is present. This is observed
for both NS3 and NS2B [in Fig. S7 boxes (a) and (b) a
few of those cross peaks are marked by arrows]. It is
likely that the major form in wild-type protein and the
only form in S135A mutant represent a conformation
where the catalytic triad is not formed. It is premature
to speculate what the minor form stands for.
The 1H-15N TROSY spectra of the S135A apo form
and those of the S135A mutant complexes with inhibi-
tors (I) and (II) are almost identical (Fig. S8a). This re-
sult was confirmed using 19F nuclei as a probe to
monitor any interaction between 15N13C-NS2B:NS3pro
(S135A) and (II), followed by the addition of (I): there
are no broad signals in regions − 81.0 to − 83.5 ppm and
− 114 to − 116.5 ppm which can be attributed to the
bound complex (Fig. S8b), i.e. no binding was observed.
Similar results were reported for interactions of small
non-peptide inhibitors with NS2B:NS3pro (S135A) [27].
Interaction of the H51N mutant with boronic acid (I) and
tfk (II) inhibitors
Another mutation introduced in the catalytic triad D75-
H51-S135 was H51N. The superposition of the 1H-15N
TROSY spectra of the apo form of NS2B:NS3pro
(H51N) and wild type NS2B:NS3pro reveals several clear
CSPs (between 0.1–0.3 ppm; Fig. S9a), in contrast to the
findings for the S135A mutant. For NS3pro, the largest
CSPs belonging to the unambiguously assigned and non-
overlapping area of the spectrum were observed for
amino acids close to N51: V52 (248 Hz), T53 (168 Hz),
R54 (44 Hz), G55 (54 Hz) and G44 (84 Hz). Some NS2B
amino acids had CSPs, but they are all below 0.1 ppm.
Comparison of the spectra of the apo form of mutants
H51N and S135A (Fig. S9b) shows that the most signifi-
cant differences are the CSPs of the amino acids V52,
T53, T48 and M49 near H51N. The disappearance of
K61 and W89 (NS3pro) and R60 and K87 (NS2B) cross
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peaks in NS2B:NS3pro (H51N) could be due to the pres-
ence of slow exchange between different conformations.
H51N mutation reduces the affinity of the tfk inhibi-
tor. This was tested by using 19F as a probe to monitor
the bound complex formation as mentioned above. The
intensity of the signals of the bound complex is de-
creased compared to those of the wild-type protein (Fig.
S10a) even if the same protein:inhibitor ratio was used
in all experiments. This observation is supported by the
appearance of weak intensity cross peaks in the 1H-15N
TROSY spectra (Fig. S10b and c), indicative of the pres-
ence of a small amount of complex of H51N mutant
with both inhibitors. Unfortunately, we cannot identify
the maximum CSP in the 1H-15N TROSY spectra of the
complexes of both inhibitors with H51N. This is due to
insufficient ligand solubility preventing us from reaching
saturation of the complex. Additionally, the apo form of
the H51N mutant is not stable at 25 °C and degraded
during a few hours. The 19F signal of the bound complex
of the H51N mutant with the 2, 6-di-fluoro-Bz groups of
Fig. 3 1D 1H spectra of the region 11-21 ppm of inhibitors (I, II) with 15N13C NS2B:NS3pro. 1D 1H spectra of the region 11-21 ppm of: (a)
15N13C-NS2B: 15N13C-NS3pro with 2,6-di-fluoro-Bz-Nle-Lys-Arg-Arg-CF3-ketone (II) in pH 6.0 MES buffer, (b)
15N13C-NS2B:NS3pro with 2,6-di-fluoro-
Bz-Nle-Lys-Arg-Arg-CF3-ketone (II) in pH 6.0 MES buffer, (c)
15N13C-NS2B: 15N13C-NS3pro with Bz-Nle-Lys-Arg-Arg-B(OH)2 (I) in pH 6.0 MES buffer,
(d)) 15N13C-NS2B: 15N13C-NS3pro with Bz-Nle-Lys-Arg-Arg-B(OH)2 (I) in pH 8.5 Tris buffer and (e)
15N13C-NS2B:NS3pro with Bz-Nle-Lys-Arg-Arg-
B(OH)2 (I) in pH 8.5 Tris buffer. The small inserts in (d) and (e) show N
δ1H of H51 second tautomer (in bold) at 19.77 ppm with the one bond J-
coupling: 1JNδ1H = 52+/− 2 Hz. For first tautomer (c in italic)
1JNδ1H = 52+/− 2 Hz for 19.93 ppm of N
δ1H of H51 and 1JNε2H = 90+/− 2 Hz for 15.59
ppm of Nε2H of H51. As reference amide backbone 1JNH = 90+/− 2 Hz of the amino acid K84 at 11.39 ppm (d) is shown
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tfk (II) is shifted significantly downfield, − 78.10 ppm,
compared to corresponding bound complex with wild
type protein, − 81.36 ppm (Fig. S10a), indicating that in
the former the 19F nucleus is more deshielded than in
the latter.
Discussion
We studied two types of inhibitors, boronic acid (I) and
tfk (II) in complex with dengue virus protease. This type
of inhibitors have been used by several groups to target
serine proteases by mimicking the intermediate complex
of the substrate to form a tetrahedral intermediate.
Monitoring 19F resonances it was demonstrated that
only one isomer of tfk type of inhibitors binds with
DENV2 NS2B:NS3pro with high affinity. Unfortunately
its configuration of Cα of the P1 (Arg) is still unknown.
The other isomer of tfk inhibitors was undergoing quick
epimerization through interaction with the enzyme. The
mechanism of epimerization can be explained by enzym-
atic enolization postulated in aldehydes, ketones and es-
ters and more studies are in progress [39, 40]. For
boronic acid (I) inhibitor the synthetic root allows to
keep the desirable D or L stereochemistry. Noteworthy,
the L isomer of boronic acid (I) did not bind with
DENV2 NS2B:NS3pro (data not shown). In general our
data corroborates earlier proposal that the model of
binding ability of either L or D isomers of boronic acid
(I) or tfk (II) inhibitors cannot be extended to the family
of serine proteases as a whole [16]. Importantly, as pre-
dicted the selection of isomers binding in active site of
DENV2 NS2B:NS3pro was unique.
We also confirmed that binding inhibitors, boronic
acid (I) and tfk (II), to DENV2 NS2B:NS3pro results in
the formation of different complexes with high affinity.
1H NMR has been used to observe the Nδ1H proton
shared between H51 and D75 which show the presence
of strong hydrogen bonds called low-barrier hydrogen
bonds (LBHB) [11]. We have found that for the complex
of the boronic acid inhibitor (I) with NS2B:NS3pro the
one-bond coupling constant Nδ1H belonging to the cata-
lytic H51 is about 38 Hz less than commonly reported
for corresponding coupling in serine proteases which are
claimed to be in range 87-95 Hz [41]. Another striking
feature is that signals at 19.933 ppm and 19.772 ppm
assigned by us to Nδ1H protons of the H51 in the cata-
lytic triad are observed at almost 1.0 ppm more down-
field than so far reported for either Nε2H or Nδ1H
protons in protonated His induced by inhibitors [33, 41].
It is noteworthy that the observed chemical shifts and
one-bond coupling constants obtained in this study for
the complex with boronic acid (I) are in accordance with
the predicted ones for LBHB type of binding if one ex-
trapolates the results of NMR study of chemical shifts
and coupling constants of the histidines within the
catalytic domain of the xylanase Cex from Cellulomonas
fimi [36]. Nevertheless, the result that Nδ1H protons of
the H51 in the catalytic triad of the complexes with (I)
are more down shifted than for complex with (II) is in
contradiction with no unusual structural and functional
features of boronic acid type inhibitor complexes re-
ported in the studies [42–44]. It also contradicts the lat-
est computational study performed on similar models of
inhibitor types (I) and (II) [12]. One way to rationalize
this discrepancy is by differences in the strengthening of
the hydrogen bond between H51 and D75 resulting from
a decrease in the dielectric constant due to the substrate
excluding water from the active site or by the induction
of steric compression between H51 and D75 [33, 45, 46].
The accessibility of water to the catalytic triad in com-
plex with bound inhibitor is a key question in order to
evaluate the mechanism of catalyst in serine proteases
and specifically fulfilling the condition of creation of the
LBHB complexes in the triad [11]. In this study we used
19F NMR to probe protein and ligand to solvent expos-
ure via solvent isotope shifts [47]. Indeed, it is known
that 19F resonances are very sensitive to solvents and
that the CS of the 19F in molecules would differ depend-
ing on the degree of exposure to different solvents. We
have shown that for both inhibitors (I) and (II) bound to
DENV2 NS2B:NS3pro, bulk water is excluded from the
active site which is favorable to the LBHB complex for-
mation. Moreover, it is known that bound water deeply
trapped in the interior of protein can play important
structural role. To identify the presence of the bound
water in the protein - ligand complexes we used an ap-
proach earlier developed by us [25]. All of the bound
waters found in the complexes are similarly distributed
and located outside the active site of the enzyme and are
unlikely to play any role in the stabilization of the cata-
lytic triad.
As a next step we examined the possible different
tautomeric structures of the tetrahedral intermediates
formed in the catalytic triad and oxyanion hole. They
have previously been discussed in the studies of other
serine proteases (Figs. 4), [16–18, 37, 42]. To be able to
perform this analysis we first need to summarize the re-
sults obtained on mutants. In this study two different
NS2B:NS3pro catalytic mutants, H51N and S135A, have
been used.
In wild type apo NS2B:NS3pro a double set of signals
were clearly observed both for NS2B and for NS3pro
[10]. For the S135A mutant, amide cross peaks belong-
ing to the catalytic H51 and G136 observed as double
peaks in wild type apo are present as single sets of peaks
in S135A spectra. They also experienced the largest CSP
(Fig. S7). For amino residues located outside the influ-
ence of the point mutation, the double set of cross peaks
“collapsed” to one set. This suggests that the S135A
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mutant seems to adopt predominantly one conform-
ation, which also is present in the wild type protein. We
argue that two sets of signals observed in apo form of
wild type NS2B:NS3pro may not be due to conformation
exchange between the open and closed conformation of
NS2B rather that they may be due to the presence of an
equilibrium between neutral S135 and H51 vs pre-
organized complex in the catalytic triad S135-H51-D75.
The only proof so far is that in the 1H-15N spectrum of
the apo S135A mutant the cross peaks are almost fully
superimposed with one set of signals and the other set is
not observed.
In the S135A mutant, the mechanism for the abstrac-
tion of the proton from the S135 hydroxyl, which then
reacts with the peptide carbonyl of the tfk (II) or bo-
ronic acid (I) inhibitors to form a tetrahedral adduct is
obviously omitted due to the absence of S135 hydroxyl.
Nevertheless, there is a study where the possibility of a
complex with a direct covalently bonded boron nucleus
of inhibitor and Nε2 of H51 of protease was proposed
for a different serine protease, (Fig. 4) [2, 18, 42]. But ac-
cording to our data on the S135A mutant this type of
complex should be ruled out for the DENV2 NS2B:NS3
proteases due to the complete absence of any binding
with boronic acid inhibitor (I).
Moreover, this experimental data also indicates that
even the binding of the P1 and P2 (Table 1) tetra peptide
of the inhibitors with corresponding binding pockets, S1
and S2, of NS3pro also did not take place in S135A mu-
tant. This allowed us to conclude that warhead inter-
action with the catalytic triad is the key step in binding
and may possibly lead to allosteric induced transform-
ation of the binding pockets, S1 and S2, to fit to the pep-
tide part of the inhibitors.
The conclusion that the formation of the tetrahedral
intermediate is taken place through interaction with
S135 agrees with NMR data obtained for catalytic mu-
tant H51N. The binding of tfk inhibitor (II) to NS2B:
NS3proH51N was observed, albeit with reduced affinity.
We propose that in this mutant the attack on the ketone
group of the inhibitor warhead by the OH group of S135
takes place and a covalent adduct can be formed but is
not stabilized: even though the leaving proton can be ac-
cepted by NH2 of N51 there is no possibility of
stabilization of the catalytic triad as a whole involving
D75. The same argument is valid for the boronic acid in-
hibitor (I) because even though the complex has been
observed the equilibrium was shifted to the apo form
and saturation of the protease and inhibitor complex
could not be reached. We can thus conclude that H51
plays a critically supportive role for the stabilization of
the tetrahedral adduct created between the inhibitor
warhead and the catalytic triad.
Based on the experimental results presented above for
the S135A and H51N mutants we ruled out the possibility
of formation of a histidine adduct complex [2] (Fig. 4)
Fig. 4 Schematic representation of possible tautomer forms of the NS2B:NS3pro active site inhibitors (I, II). Schematic representation of
possible tautomer forms of the NS2B:NS3pro active site with boronic acid inhibitor (I): Bz-Nle-Lys-Arg-Arg-B(OH)2 [1]– [5] and with tfk inhibitor (II):
di-fluoro-Bz-Nle-Lys-Arg-Arg-CF3-ketone [6]
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described earlier for α-lytic proteases [18, 42], as well as
structure [3] which was used in a structure refinement
protocol based on NMR nOe data for the complex NS2B:
NS3pro with (II) [21]. We arrive at this conclusion based
on the result that for both of S135A and H51N mutants
the complex with (I) and (II) inhibitors were either not
formed or in a small quantity, respectively. The tauto-
meric structure [1], (Fig. 4) which is proposed as tetrahe-
dral intermediate [12, 17, 18, 42, 43, 48, 49], could be
matched to the observed experimental data in this study
only with ambiguity. Indeed, even if we have observed the
presence of the minor conformation as a very unstable
form for the NS2B:NS3pro with (I), we did not observe
interaction of G133 in the oxyanion hole, predicted by this
structure. The structure [4], (Fig. 4) was earlier proposed
but its existence was never proven [18]. It is not clear how
the proton from structure [1] could be eliminated leading
to structure [4].
Here we propose that NS2B:NS3pro with boronic acid
(I) can form and exist in a stable form as intermediate
[5]. The possibility of the boronic acid inhibitor to form
two covalent bond, Ser Oγ and His Nε2 to boron bonds,
in serine protease was postulated in NMR [42, 50–52],
and x-ray [16, 17, 49] studies. One way to arrive at this
structure is losing a water molecule from intermediate
[1, 17, 50].
Despite that both intermediates [5] and [6] (Fig. 4)
NS2B:NS3pro with (1) and (II) inhibitors respectively
adopt slightly different strength of LBHB hydrogen
bonds observed by NMR between the Nδ1 proton shared
between H51and D75 it cannot account for the large dif-
ference in binding affinity of these inhibitors: the former
has higher affinity than the latter. One would expect
additional stabilization of the intermediate [6] in NS2B:
NS3pro with (II) inhibitor due to the hydrogen bond of
the hemiketal oxygen of the tetrahedral intermediate
with an NH of an oxyanion hole amide, G133 and S135,
is expected to provide a benefit for the stability of inter-
mediate [6] vs [5] which was not the case. In this study
we conclude that presence of LBHB bonds or/and add-
itional hydrogen bonding in the oxyanion hole are ne-
cessary but not sufficient factors in stabilization of the
intermediate complexes [6] vs to [5]. Other factors could
play important roles in the relative stability of these
intermediate. One of them is the difference in strength
of the formed covalent (H51)Nε2 –B bond in tautomer
[5] of NS2B:NS3pro with (I) vs the hydrogen bond
(H51)Nε2-H…F in tautomer [6] of NS2B:NS3pro with
(II). Existence of the latter was proposed in the x-ray
study of the structure of chymotrypsin with tfk inhibitor
[53]. Noteworthy that in the 19F-1H Hoesy spectrum
(Fig. S11) of the complex NS2B:NS3pro with tfk (IV) we
have observed an nOe cross peak between the 19F nuclei
of the CF3- group and (H51)H
δ2 proton supporting the
formation of tautomer [6]. Importantly, the total length
of the catalytic triad between D75 and the boronic nuclei
in [5] is shorter than in [6] between D75 and the hemi-
ketal carbon of inhibitors [5, 6], (Fig. 4). Due to that, a
more compact catalytic active site can be formed in the
former than in the latter. This means that mimicking of
the di-covalent adduct [5] of boronic acid (I) could lead
to the more potent inhibitor in DENV2 NS2B:NS3 pro-
teases than inhibitor (II) mimicking natural substrates.
Our finding can play an important role in modelling
studies bearing in mind that the computational approach
of DENV2 NS2B:NS3 so far reported, has been restricted
to covalent serine adducts: for tfk [21], and for boronic
acid [29]. The role of compressions of the catalytic triad
on the stability of the complex DENV2 NS2B:NS3 prote-
ases as a whole is the subject of our future study.
Conclusions
In this work, unlinked NS2B:NS3pro and two catalytic
NS3pro mutants, S135A and H51N, were studied by
NMR spectroscopy with different peptidic inhibitors
mimicking the catalytic tetrahedral intermediate. The in-
hibitors contain the same tetra peptide moiety with dif-
ferent ‘warheads’ (boronic acid (I) and trifluoroketone
(II)) on the C-end and bind with different affinity to the
DENV2 NS2B:NS3pro.
Our result obtained for the investigated complexes in-
dicates that there are some crucial differences between
the conformations adopted in the active site of enzyme.
Firstly there is no interaction with the oxyanion hole in
the di-covalent adduct [5] formed as intermediate with
boronic acid (I), compared to the tetrahedral adduct [6]
formed with tfk (II). Secondly, the covalent (H51)Nε2 –B
bond vs hydrogen bond (H51)Nε2-H…F formed for the
former vs latter, respectively, the fact that we observe
different type of cross-links between protein and ligands
we attribute to the plastic topology of the active site of the
DENV2 NS2B:NS3pro. We suggest that the boronic ligand
(I), poorly resembling a natural substrates carries a prom-
ising inhibition property for drug design. The tfk (II)
makes good transition-state analogs, binding to the cata-
lytic serine in line with other serine proteases. The finding
that the binding site shows preference for different iso-
mers need also be taken into account when designing
drugs targeting DENV2 NS2B:NS3pro. This study indi-
cates flexibility, most likely with the different parts being
at least partially independent of each other, of the active
site of DENV2 NS2B:NS3pro and that further studies are
needed to determine if this is indeed the case and if it is
the backbone and/or sidechains that are responsible and
the magnitude of the indicated flexibility.
Our reported findings will, together with more struc-
tural and dynamic measurements on the complex NS3:
NS2B:ligand, which is ongoing, facilitate the development
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of rational structure based inhibitors that can selectively
target the NS3 protease of Dengue type II (DENV2) virus.
Methods
Protein expression and purification
Reagents were from Sigma (St. Louis, MO, USA) unless
otherwise stated. DENV2 NS3pro (1–185; amino acids
1476–1660 of the polyprotein) and NS2B (containing
amino acids 1394–1440 of the Dengue 2 polyprotein)
constructs were generated as described [10]. H51N and
S135A mutations of active site residues were introduced
using the QuikChange Lightning kit (Agilent); a double
H51N/S135A mutant was generated sequentially. All se-
quences were confirmed by Sanger sequencing. NS2B
and NS3pro were expressed separately in Escherichia coli
expression strain BL21Star (DE3) (Life Technologies) as
described [10]. Proteins were expressed in Terrific Broth
medium (MP Biomedicals) for unlabelled protein or in
different isotopic labelling combinations in 1/2H, 15N,
12/13C-labelled M9 medium for labelled protein [54].
Chemicals for isotope labelling (ammonium chloride,
15N (99%), D-glucose, 13C (99%), deuterium oxide) were
purchased from Cambridge Isotope Laboratories, Inc.
Incorporation of 13C15N-histidine (Cambridge Isotope
Laboratories) was done as described by [55], NS3pro
was grown at 37 °C in Terrific Broth medium until
OD600 reached 1.3. Cells were then pelleted by centrifu-
gation, washed in PBS and re suspended in pre warmed
M9 medium supplemented with 0.2 mM 13C15N-histi-
dine. After incubation for one additional hour at 230
rpm and 37 °C, expression was induced with IPTG, and
cells were harvested by centrifugation after three more
hours at 230 rpm and 37 °C.
Purification: NS2B and NS3pro were co-refolded by
one-step dialysis overnight at 4 °C in a 2:1M NS2B:
NS3pro ratio to maximize formation of the active com-
plex. The refolding buffer was 25 mM Tris pH 8.5 (pH
set at 4 °C), 5% glycerol, 100 mM NaCl. Thrombin (GE
Healthcare) and/or TEV protease (produced in house ac-
cording to [56]) was added to a dialysis cassette (3500 or
7000 MWCO Slide-A-Lyzer, Thermo Fisher Scientific)
to cleave off the His tag from NS2B and/or NS3pro.
Thrombin could be added directly, and did not lose ac-
tivity in the high concentration urea solution of the dia-
lysis cassette, while TEV protease was added 1 h after
starting the dialysis. After refolding the solution was
centrifuged at 50,000×g to remove any precipitate or
particles. Refolding yield was determined by measuring
protein concentration of the two IMAC pools (NS2B: ε
5500, MW 7.7 kDa; NS3pro: ε 36,400, MW 21.0 kDa) be-
fore refolding and comparing that to the protein concen-
tration after refolding and centrifugation (complex: ε 41,
940, MW 28.7 kDa), using a Nanodrop 1000 instrument
(Thermo Scientific). The complex was then purified on
an ÄKTA Explorer (GE Healthcare) by size exclusion on
a HiLoad Superdex 200 column (GE Healthcare) in SEC
buffer: 50 mM Tris pH 8.5 (4 °C), 5% glycerol, 50 mM
NaCl.
Protease inhibitors
The NS3pro inhibitors Bz-Nle-Lys-Arg-Arg-B(OH)2 (I)
and 2,6-di-fluoro-Bz-Nle-Lys-Arg-Arg-CF3-ketone and
Bz-Nle-Lys-Arg-Arg-CF3 (II-V) used in this study were
synthesized according to the reaction schemes published
in the original paper [44].
Biochemical assay
Activity assays were carried out on a 96-well plate (white
Cliniplate, Thermo Fisher Scientific Oy, Vantaa, Finland)
in 50mM HEPES, pH 7.4, 150mM NaCl, 10% ethylene
glycol, 0.05% BSA, 0.0016% Brij-58 with 80 nM enzyme
using 20 μM Bz-nle-Lys-Arg-Arg-AMC (Bachem, Buben-
dorf, Switzerland) as substrate. Reagents were from Sigma
(St. Louis, MO, USA) unless otherwise stated.
5 μl of 200 μM substrate in buffer and 2.5 μl of com-
pound in DMSO or DMSO control were added to the
plate. 42.5 μl of 94 μM enzyme in buffer was added to
start the reaction. Fluorescence was read every 30 s for
30 min at 390 nm excitation and 460 nm emission in a
Fluorskan Ascent plate reader (Thermo Fisher Scientific
Oy, Vantaa, Finland). Rates were fitted in the Ascent
software and exported as Excel files. The rates were
imported into GraphPad Prism (GraphPad Software Inc.,
La Jolla, CA, USA) and fitted to the standard three par-
ameter IC50 equation.
NMR samples preparation
The NS2B:NS3pro complex was concentrated in dispos-
able centrifugal concentrators (e.g. Amicon Ultra centri-
fugal filter units) with a molecular weight cut-off of 10
kDa. The complex was stable during concentration and
no leakage of NS2B occurred. Buffer was exchanged
using gravity flow desalting columns (GE Healthcare).
The NMR buffer contained 20mM deuterated MES,
100 mM NaCl, 5 mM CaCl2, 0.02% NaN3, at pH 6.5. The
buffer-exchanged protein was concentrated to at least
0.3 mM. To obtain spectra in D2O buffer protein com-
plex with inhibitor was lyophilized and dissolved adding
only D2O water.
NMR spectroscopy
NMR experiments were acquired on Bruker Avance III
spectrometers operating at 14.1 and 16.4 T at a temperature
of 298 K. 2D 1H-15N TROSY -transverse relaxation opti-
mized spectroscopy (TROSY) was used [57–59]. 19F experi-
ments were acquired on a Bruker Avance III 16.4 T
equipped with a QCIF CryoProbe, and internally referenced
to the trifluoromethyl acetate counter ion (− 76.55 ppm).
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For solvent isotope shift measurements the buffer was ex-
changed from 90% H2O to 90% D2O using centrifugation
filters by following dilution of the sample till starting con-
centration. The consistency of the procedure has been
tested through comparison of the 1H-15N spectra before
and after buffer exchange back to starting condition. There
was no major structural perturbations resulted from ex-
change into deuterated buffer conditions. Protein detected
experiments with ligand bound used a chemical shift per-
turbation (CSP) analysis was performed manually in
CcpNmr Analysis 2.2.2 [60]. CSP was defined as the dis-
tance between two cross peaks in Hz, obtained as the
square root of the sum of quadratic using DANGLE [61].
Protein assignment
Backbone resonance assignment of the NS2B:NS3pro
with tetra peptide boronic acid (I) was performed as de-
scribed previously by us with depositing to the BioMa-
gResBank with accession code 26996 [10, 62], and
compared with published earlier for the same inhibitor
complex but with the linked construct Dengue I NS2B:
NS3pro (BioMagResBank with accession code 19305).
Backbone resonance assignment have been done in the
same manner for the complex NS2B:NS3pro with the
tetra peptide tfk ligand (II) as well and will be published
elsewhere. Partial assignments of the 1H and 15N reso-
nances presented in this publication of the apo form
NS2B:NS3pro and its mutants in complex with inhibi-
tors observed to the uncrowded area of the 1H-15N spec-
tra are made by the extrapolation of corresponding cross
peaks to the closest one known amino acids using CCPN
program tool. The assignment both aromatic and imide
1H and 15N resonances of the three histidines (His) pre-
sented in sequence of the NS3pro was subsequently con-
firmed by the comparison between the 1H-15N HSQC
spectra of the enzymes: the complex uniformly labelled
2H13C15N-NS3pro and unlabeled NS2B versus specific-
ally 15N13C His labelled NS3pro on the unlabelled back-
ground and unlabeled NS2B. Both samples are in
complex with the boronic acid type inhibitor, (I), inhibi-
tor (see additional Supporting Information).
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